Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

Longitudinal natural history in young boys with Duchenne muscular dystrophy.

Coratti G, Brogna C, Norcia G, Ricotti V, Abbott L, D'Amico A, Berardinelli A, Vita GL, Lucibello S, Messina S, Sansone V, Albamonte E, Colia G, Salmin F, Gardani A, Manzur A, Main M, Baranello G, Arnoldi MT, Parsons J, Carry T, Connolly AM, Bertini E, Muntoni F, Pane M, Mercuri E.

Neuromuscul Disord. 2019 Sep 26. pii: S0960-8966(19)31130-7. doi: 10.1016/j.nmd.2019.09.010. [Epub ahead of print]

PMID:
31629611
2.

Sleep disorders in low-risk preschool very preterm children.

Romeo DM, Leo G, Lapenta L, Leone D, Turrini I, Brogna C, Gallini F, Cota F, Vento G, Mercuri E.

Sleep Med. 2019 May 27;63:137-141. doi: 10.1016/j.sleep.2019.04.016. [Epub ahead of print]

PMID:
31627127
3.

Predominant distal muscle involvement in spinal muscular atrophy.

Brogna C, Cristiano L, Verdolotti T, Ficociello L, Pera MC, Antonaci L, De Sanctis R, Pichiecchio A, Cinnante CM, Tartaglione T, Colosimo C, Pane M, Mercuri E.

Neuromuscul Disord. 2019 Sep 13. pii: S0960-8966(19)31109-5. doi: 10.1016/j.nmd.2019.09.002. [Epub ahead of print] No abstract available.

PMID:
31606281
4.

Development of an academic disease registry for spinal muscular atrophy.

Mercuri E, Finkel R, Scoto M, Hall S, Eaton S, Rashid A, Balashkina J, Coratti G, Pera MC, Samsuddin S, Civitello M, Muntoni F; iSMAC Group.

Neuromuscul Disord. 2019 Aug 29. pii: S0960-8966(19)31105-8. doi: 10.1016/j.nmd.2019.08.014. [Epub ahead of print]

PMID:
31558335
5.

European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

Barp A, Laforet P, Bello L, Tasca G, Vissing J, Monforte M, Ricci E, Choumert A, Stojkovic T, Malfatti E, Pegoraro E, Semplicini C, Stramare R, Scheidegger O, Haberlova J, Straub V, Marini-Bettolo C, Løkken N, Diaz-Manera J, Urtizberea JA, Mercuri E, Kynčl M, Walter MC, Carlier RY.

J Neurol. 2019 Sep 25. doi: 10.1007/s00415-019-09539-y. [Epub ahead of print]

PMID:
31555977
6.

Performance of Upper Limb module for Duchenne muscular dystrophy.

Mayhew AG, Coratti G, Mazzone ES, Klingels K, James M, Pane M, Straub V, Goemans N, Mercuri E; Pul Working Group.

Dev Med Child Neurol. 2019 Sep 19. doi: 10.1111/dmcn.14361. [Epub ahead of print]

PMID:
31538331
7.

Next-generation sequencing approach to hyperCKemia: A 2-year cohort study.

Rubegni A, Malandrini A, Dosi C, Astrea G, Baldacci J, Battisti C, Bertocci G, Donati MA, Dotti MT, Federico A, Giannini F, Grosso S, Guerrini R, Lenzi S, Maioli MA, Melani F, Mercuri E, Sacchini M, Salvatore S, Siciliano G, Tolomeo D, Tonin P, Volpi N, Santorelli FM, Cassandrini D.

Neurol Genet. 2019 Aug 16;5(5):e352. doi: 10.1212/NXG.0000000000000352. eCollection 2019 Oct.

8.

Early neurodevelopmental characterization in children with cobalamin C/defect.

Ricci D, Martinelli D, Ferrantini G, Lucibello S, Gambardella ML, Olivieri G, Chieffo D, Battaglia D, Diodato D, Iarossi G, Donati A, Dionisi-Vici C, Battini R, Mercuri E.

J Inherit Metab Dis. 2019 Sep 10. doi: 10.1002/jimd.12171. [Epub ahead of print]

PMID:
31503356
9.

Long-term progression in type II spinal muscular atrophy: A retrospective observational study.

Mercuri E, Lucibello S, Pera MC, Carnicella S, Coratti G, de Sanctis R, Messina S, Mazzone E, Forcina N, Fanelli L, Norcia G, Antonaci L, Frongia AL, Pane M.

Neurology. 2019 Sep 24;93(13):e1241-e1247. doi: 10.1212/WNL.0000000000008166. Epub 2019 Aug 26.

PMID:
31451515
10.

Early Neurological Assessment in Infants with Hypoxic Ischemic Encephalopathy Treated with Therapeutic Hypothermia.

Romeo DM, Bompard S, Serrao F, Leo G, Cicala G, Velli C, Gallini F, Priolo F, Vento G, Mercuri E.

J Clin Med. 2019 Aug 18;8(8). pii: E1247. doi: 10.3390/jcm8081247.

11.

An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.

Darras BT, Farrar MA, Mercuri E, Finkel RS, Foster R, Hughes SG, Bhan I, Farwell W, Gheuens S.

CNS Drugs. 2019 Sep;33(9):919-932. doi: 10.1007/s40263-019-00656-w.

12.

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry.

Muntoni F, Desguerre I, Guglieri M, Osorio AN, Kirschner J, Tulinius M, Buccella F, Elfring G, Werner C, Schilling T, Trifillis P, Zhang O, Delage A, Santos CL, Mercuri E.

J Comp Eff Res. 2019 Aug 15. doi: 10.2217/cer-2019-0086. [Epub ahead of print]

13.

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.

Brogna C, Coratt G, Pane M, Ricotti V, Messina S, D'Amico A, Bruno C, Vita G, Berardinelli A, Mazzone E, Magri F, Ricci F, Mongini T, Battini R, Bello L, Pegoraro E, Baranello G, Previtali SC, Politano L, Comi GP, Sansone VA, Donati A, Bertini E, Muntoni F, Goemans N, Mercuri E; on behalf on the International DMD group.

PLoS One. 2019 Jul 31;14(7):e0220714. doi: 10.1371/journal.pone.0220714. eCollection 2019.

14.

Neonatal hypotonia and neuromuscular conditions.

Mercuri E, Pera MC, Brogna C.

Handb Clin Neurol. 2019;162:435-448. doi: 10.1016/B978-0-444-64029-1.00021-7.

PMID:
31324324
15.

Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy.

Montes J, Dunaway Young S, Mazzone ES, Pasternak A, Glanzman AM, Finkel RS, Darras BT, Muntoni F, Mercuri E, De Vivo DC, Bishop KM, Schneider E, Bennett CF, Foster R, Farwell W; CS2 and CS12 Study Groups.

Muscle Nerve. 2019 Oct;60(4):409-414. doi: 10.1002/mus.26633. Epub 2019 Jul 27.

16.

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53.

Brogna C, Coratti G, Pane M, Ricotti V, Messina S, D'Amico A, Bruno C, Vita G, Berardinelli A, Mazzone E, Magri F, Ricci F, Mongini T, Battini R, Bello L, Pegoraro E, Baranello G, Previtali SC, Politano L, Comi GP, Sansone VA, Donati A, Bertini E, Muntoni F, Goemans N, Mercuri E; on behalf on the International DMD group.

PLoS One. 2019 Jun 25;14(6):e0218683. doi: 10.1371/journal.pone.0218683. eCollection 2019. Erratum in: PLoS One. 2019 Jul 31;14(7):e0220714.

17.

Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data.

Pane M, Coratti G, Sansone VA, Messina S, Bruno C, Catteruccia M, Sframeli M, Albamonte E, Pedemonte M, D'Amico A, Bravetti C, Berti B, Brigati G, Tacchetti P, Salmin F, de Sanctis R, Lucibello S, Piastra M, Genovese O, Bertini E, Vita G, Tiziano FD, Mercuri E; Italian Expanded Access Program Working Group.

Ann Neurol. 2019 Sep;86(3):443-451. doi: 10.1002/ana.25533. Epub 2019 Jul 8.

PMID:
31228281
18.

Image-based anatomical reconstruction and pharmaco-mediated bone remodeling model applied to a femur with subtrochanteric fracture: A subject-specific finite element study.

Bahia MT, Hecke MB, Mercuri EGF.

Med Eng Phys. 2019 Jul;69:58-71. doi: 10.1016/j.medengphy.2019.05.005. Epub 2019 Jun 4.

PMID:
31171487
19.

Neurofilament as a potential biomarker for spinal muscular atrophy.

Darras BT, Crawford TO, Finkel RS, Mercuri E, De Vivo DC, Oskoui M, Tizzano EF, Ryan MM, Muntoni F, Zhao G, Staropoli J, McCampbell A, Petrillo M, Stebbins C, Fradette S, Farwell W, Sumner CJ.

Ann Clin Transl Neurol. 2019 Apr 17;6(5):932-944. doi: 10.1002/acn3.779. eCollection 2019 May.

20.

Diagnostic performance of new and classic CSF biomarkers in age-related dementias.

Marchegiani F, Matacchione G, Ramini D, Marcheselli F, Recchioni R, Casoli T, Mercuri E, Lazzarini M, Giorgetti B, Cameriere V, Paolini S, Paciaroni L, Rossi T, Galeazzi R, Lisa R, Bonfigli AR, Procopio AD, De Luca M, Pelliccioni G, Olivieri F.

Aging (Albany NY). 2019 Apr 27;11(8):2420-2429. doi: 10.18632/aging.101925.

21.

Clinical features and genetic analysis of two siblings with startle disease in an Italian family: a case report.

Sprovieri T, Ungaro C, Sivo S, Quintiliani M, Contaldo I, Veredice C, Citrigno L, Muglia M, Cavalcanti F, Cavallaro S, Mercuri E, Battaglia D.

BMC Med Genet. 2019 Mar 12;20(1):40. doi: 10.1186/s12881-019-0779-x.

22.

Value of structured reporting in neuromuscular disorders.

Alessandrino F, Cristiano L, Cinnante CM, Tartaglione T, Gerevini S, Verdolotti T, Colafati GS, Ghione E, Vitale R, Peverelli L, Brogna C, Berardinelli A, Moggio M, Mercuri EM, Pichiecchio A.

Radiol Med. 2019 Jul;124(7):628-635. doi: 10.1007/s11547-019-01012-0. Epub 2019 Mar 9.

PMID:
30852791
23.

An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy.

Jokela M, Tasca G, Vihola A, Mercuri E, Jonson PH, Lehtinen S, Välipakka S, Pane M, Donati M, Johari M, Savarese M, Huovinen S, Isohanni P, Palmio J, Hartikainen P, Udd B.

Neurology. 2019 Apr 2;92(14):e1600-e1609. doi: 10.1212/WNL.0000000000007246. Epub 2019 Mar 6.

PMID:
30842289
24.

Resolution of skin necrosis after nusinersen treatment in an infant with spinal muscular atrophy.

Salmin F, Albamonte E, Morettini V, Gagliano N, Mercuri E, Sansone VA.

Muscle Nerve. 2019 Jun;59(6):E42-E44. doi: 10.1002/mus.26457. Epub 2019 Mar 22. No abstract available.

PMID:
30811610
25.

Revised upper limb module for spinal muscular atrophy: 12 month changes.

Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, Main M, Mayhew A, Muni Lofra R, Dunaway Young S, Glanzman AM, Duong T, Pasternak A, Ramsey D, Darras B, Day JW, Finkel RS, De Vivo DC, Sormani MP, Bovis F, Straub V, Muntoni F, Pane M, Mercuri E; iSMAC Consortium Group.

Muscle Nerve. 2019 Apr;59(4):426-430. doi: 10.1002/mus.26419. Epub 2019 Feb 7.

PMID:
30677148
26.

Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol.

Tiziano FD, Lomastro R, Abiusi E, Pasanisi MB, Di Pietro L, Fiori S, Baranello G, Angelini C, Sorarù G, Gaiani A, Mongini T, Vercelli L, Mercuri E, Vasco G, Pane M, Vita G, Vita G, Messina S, Petillo R, Passamano L, Politano L, Campanella A, Mantegazza R, Morandi L.

J Med Genet. 2019 May;56(5):293-300. doi: 10.1136/jmedgenet-2018-105482. Epub 2018 Dec 28.

PMID:
30593463
27.

The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy.

Kletzl H, Marquet A, Günther A, Tang W, Heuberger J, Groeneveld GJ, Birkhoff W, Mercuri E, Lochmüller H, Wood C, Fischer D, Gerlach I, Heinig K, Bugawan T, Dziadek S, Kinch R, Czech C, Khwaja O.

Neuromuscul Disord. 2019 Jan;29(1):21-29. doi: 10.1016/j.nmd.2018.10.001. Epub 2018 Oct 30.

PMID:
30553700
28.

Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.

Sansone VA, Albamonte E, Salmin F, Casiraghi J, Pirola A, Bettinelli M, Rao F, Mancini L, Tovaglieri N, Fedeli F, Stoia P, Heinen M, Cozzi V, Carraro E, Lunetta C, Di Bari A, Mercuri E; Italian EAP working group.

Neurol Sci. 2019 Feb;40(2):327-332. doi: 10.1007/s10072-018-3622-9. Epub 2018 Nov 15.

PMID:
30430317
29.

Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients.

Giugliano T, Savarese M, Garofalo A, Picillo E, Fiorillo C, D'Amico A, Maggi L, Ruggiero L, Vercelli L, Magri F, Fattori F, Torella A, Ergoli M, Rubegni A, Fanin M, Musumeci O, Bleecker J, Peverelli L, Moggio M, Mercuri E, Toscano A, Mora M, Santoro L, Mongini T, Bertini E, Bruno C, Minetti C, Comi GP, Santorelli FM, Angelini C, Politano L, Piluso G, Nigro V.

Genes (Basel). 2018 Oct 26;9(11). pii: E524. doi: 10.3390/genes9110524.

30.

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.

Astrea G, Romano A, Angelini C, Antozzi CG, Barresi R, Battini R, Battisti C, Bertini E, Bruno C, Cassandrini D, Fanin M, Fattori F, Fiorillo C, Guerrini R, Maggi L, Mercuri E, Morani F, Mora M, Moro F, Pezzini I, Picillo E, Pinelli M, Politano L, Rubegni A, Sanseverino W, Savarese M, Striano P, Torella A, Trevisan CP, Trovato R, Zaraieva I, Muntoni F, Nigro V, D'Amico A, Santorelli FM; Italian CMD Network.

Orphanet J Rare Dis. 2018 Sep 26;13(1):170. doi: 10.1186/s13023-018-0863-x.

31.

Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?

Pera MC, Luigetti M, Sivo S, Lapenta L, Granata G, Antonaci L, Coratti G, Forcina N, Pane M, Mercuri E.

Neuromuscul Disord. 2018 Oct;28(10):863-864. doi: 10.1016/j.nmd.2018.07.013. Epub 2018 Aug 4. No abstract available.

PMID:
30177455
32.

Genetic therapies for inherited neuromuscular disorders.

Scoto M, Finkel R, Mercuri E, Muntoni F.

Lancet Child Adolesc Health. 2018 Aug;2(8):600-609. doi: 10.1016/S2352-4642(18)30140-8. Epub 2018 Jun 27. Review.

PMID:
30119719
33.

Brain morphometry of preschool age children affected by autism spectrum disorder: Correlation with clinical findings.

Lucibello S, Verdolotti T, Giordano FM, Lapenta L, Infante A, Piludu F, Tartaglione T, Chieffo D, Colosimo C, Mercuri E, Battini R.

Clin Anat. 2019 Jan;32(1):143-150. doi: 10.1002/ca.23252.

PMID:
30113100
34.

An observational study of functional abilities in infants, children, and adults with type 1 SMA.

Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, Sframeli M, Albamonte E, Pedemonte M, D'Amico A, Brigati G, de Sanctis R, Coratti G, Lucibello S, Bertini E, Vita G, Danilo Tiziano F, Mercuri E; Italian EAP Working Group.

Neurology. 2018 Aug 21;91(8):e696-e703. doi: 10.1212/WNL.0000000000006050. Epub 2018 Jul 25.

35.

Report on the workshop: Meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30-31 January 2017.

Straub V, Mercuri E; DMD outcome measure study group.

Neuromuscul Disord. 2018 Aug;28(8):690-701. doi: 10.1016/j.nmd.2018.05.013. Epub 2018 Jun 6. No abstract available.

PMID:
30033203
36.

Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function.

Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, Sframeli M, Albamonte E, Pedemonte M, D'Amico A, Brigati G, de Sanctis R, Coratti G, Lucibello S, Bertini E, Vita G, Tiziano FD, Mercuri E; Italian EAP working group.

Neuromuscul Disord. 2018 Jul;28(7):582-585. doi: 10.1016/j.nmd.2018.05.010. Epub 2018 Jun 1.

PMID:
29960818
37.

Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.

Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, Ramsey D, Milev E, Civitello M, Pane M, Pera MC, Scoto M, Day JW, Tennekoon G, Finkel RS, Darras BT, Muntoni F, De Vivo DC, Mercuri E.

PLoS One. 2018 Jun 26;13(6):e0199657. doi: 10.1371/journal.pone.0199657. eCollection 2018.

38.

Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy.

Brogna C, Cristiano L, Tartaglione T, Verdolotti T, Fanelli L, Ficociello L, Tasca G, Battini R, Coratti G, Forcina N, De Santis R, Norcia G, Carnicella S, Colosimo C, Carlier P, Pane M, Mercuri E.

PLoS One. 2018 Jun 20;13(6):e0199222. doi: 10.1371/journal.pone.0199222. eCollection 2018.

39.

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.

Pane M, Coratti G, Brogna C, Mazzone ES, Mayhew A, Fanelli L, Messina S, D'Amico A, Catteruccia M, Scutifero M, Frosini S, Lanzillotta V, Colia G, Cavallaro F, Rolle E, De Sanctis R, Forcina N, Petillo R, Barp A, Gardani A, Pini A, Monaco G, D'Angelo MG, Zanin R, Vita GL, Bruno C, Mongini T, Ricci F, Pegoraro E, Bello L, Berardinelli A, Battini R, Sansone V, Albamonte E, Baranello G, Bertini E, Politano L, Sormani MP, Mercuri E.

PLoS One. 2018 Jun 20;13(6):e0199223. doi: 10.1371/journal.pone.0199223. eCollection 2018.

40.

Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.

Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, Ramsey D, Muni Lofra R, Coratti G, Fanelli L, De Sanctis R, Forcina N, Chiriboga C, Darras BT, Tennekoon GI, Scoto M, Day JW, Finkel R, Muntoni F, Mercuri E, De Vivo DC.

Pediatr Phys Ther. 2018 Jul;30(3):209-215. doi: 10.1097/PEP.0000000000000515.

PMID:
29924070
41.

Neurological assessment of late-preterm infants during the first year of age.

Romeo DM, Brogna C, Mercuri E.

Eur J Paediatr Neurol. 2018 Jul;22(4):579-580. doi: 10.1016/j.ejpn.2018.05.011. No abstract available.

PMID:
29887413
42.

Evaluator Training and Reliability for SMA Global Nusinersen Trials1.

Glanzman AM, Mazzone ES, Young SD, Gee R, Rose K, Mayhew A, Nelson L, Yun C, Alexander K, Darras BT, Zolkipli-Cunningham Z, Tennekoon G, Day JW, Finkel RS, Mercuri E, De Vivo DC, Baldwin R, Bishop KM, Montes J.

J Neuromuscul Dis. 2018;5(2):159-166. doi: 10.3233/JND-180301.

43.

Effects of Lycra suits in children with cerebral palsy.

Romeo DM, Specchia A, Sini F, Bompard S, Di Polito A, Del Vecchio A, Ferrara P, Bernabei R, Mercuri E.

Eur J Paediatr Neurol. 2018 Sep;22(5):831-836. doi: 10.1016/j.ejpn.2018.04.014. Epub 2018 May 3.

PMID:
29802022
45.

A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript "single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1" written by pechmann and colleagues".

Sansone VA, Pane M, Messina S, Bruno C, D'Amico A, Albamonte E, Catteruccia M, Sframeli M, Pedemonte M, Vita G, Bertini E, Mercuri E; Italian ISMAc Group.

Eur J Paediatr Neurol. 2018 Jul;22(4):729-731. doi: 10.1016/j.ejpn.2018.02.004. Epub 2018 Feb 19. No abstract available.

PMID:
29673809
46.

Evidence-based care in Duchenne muscular dystrophy.

McDonald CM, Mercuri E.

Lancet Neurol. 2018 May;17(5):389-391. doi: 10.1016/S1474-4422(18)30115-7. No abstract available.

PMID:
29656735
47.

Joint Laxity in Preschool Children Born Preterm.

Romeo DM, Velli C, Lucibello S, Ferrantini G, Leo G, Brogna C, Cota F, Ricci D, Gallini F, Romagnoli C, Vento G, Mercuri E.

J Pediatr. 2018 Jun;197:104-108. doi: 10.1016/j.jpeds.2018.02.008. Epub 2018 Apr 9.

PMID:
29650414
48.

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.

Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, Iannaccone ST, Kirschner J, Kuntz NL, Saito K, Shieh PB, Tulinius M, Mazzone ES, Montes J, Bishop KM, Yang Q, Foster R, Gheuens S, Bennett CF, Farwell W, Schneider E, De Vivo DC, Finkel RS; CHERISH Study Group.

N Engl J Med. 2018 Feb 15;378(7):625-635. doi: 10.1056/NEJMoa1710504.

49.

Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.

Savarese M, Maggi L, Vihola A, Jonson PH, Tasca G, Ruggiero L, Bello L, Magri F, Giugliano T, Torella A, Evilä A, Di Fruscio G, Vanakker O, Gibertini S, Vercelli L, Ruggieri A, Antozzi C, Luque H, Janssens S, Pasanisi MB, Fiorillo C, Raimondi M, Ergoli M, Politano L, Bruno C, Rubegni A, Pane M, Santorelli FM, Minetti C, Angelini C, De Bleecker J, Moggio M, Mongini T, Comi GP, Santoro L, Mercuri E, Pegoraro E, Mora M, Hackman P, Udd B, Nigro V.

JAMA Neurol. 2018 May 1;75(5):557-565. doi: 10.1001/jamaneurol.2017.4899. Erratum in: JAMA Neurol. 2018 Nov 1;75(11):1443.

50.

Motor neuron disease: A prospective natural history study of type 1 spinal muscular atrophy.

Bertini E, Mercuri E.

Nat Rev Neurol. 2018 Apr;14(4):197-198. doi: 10.1038/nrneurol.2017.189. Epub 2018 Jan 19. No abstract available.

PMID:
29348544

Supplemental Content

Loading ...
Support Center